
Bloomberg reports QIAGEN’s supervisory board may soon back EQT’s proposed bid, though no final decision has been made.
EQT is reportedly close to making a takeover offer for QIAGEN at €46.50 per share, Bloomberg reported, citing people familiar with the matter. QIAGEN’s supervisory board is expected to approve the offer soon, though no final decision has been made.
The bid would value the diagnostics company at nearly €10 billion. Bloomberg said an official announcement could come on Wednesday.
QIAGEN had said in spring that it was reviewing strategic options with the help of banks. Its shares traded at $50, up 2.25% from the previous close, as of 20:00 UTC Wednesday.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.